STEM CELLS, the premier peer-reviewed journal in the field of stem cells and regenerative medicine, has promoted Jan A. Nolta to editor.
Nolta, one of the nation's leading researchers in regenerative medicine, directs the UC Davis Institute for Regenerative Cures, a facility supported by the California Institute for Regenerative Medicine. In addition to conducting groundbreaking research in human stem cells, she oversees the university's stem cell program, which includes more than 150 faculty scientists and clinicians on the Davis and Sacramento campuses.
"There has never been such an exciting time to be a scientist in the field of stem cell research," said Nolta, who is a professor of internal medicine. "The tools and techniques that we now have are unprecedented and allow us to probe the biology of stem cells in entirely new ways. I look forward to tackling my new role with both a zeal and deep respect for the global scientific community."
Nolta joined UC Davis in 2006 after serving for four years as scientific director of the cell and gene therapy Good Manufacturing Practice (GMP) facility at Washington University School of Medicine, St. Louis. Her translational research has focused on developing improved stem cell therapies for treating neurodegenerative diseases, including Huntington's and Parkinson's disease, immunodeficiencies, lysosomal storage diseases and peripheral vascular disease.
Nolta has had more than 20 years experience in the stem cell field. She has published more than 100 peer-reviewed manuscripts in the field of regenerative medicine and has authored 25 book chapters and numerous invited papers. She was author and editor of the book, "Genetic Engineering of Mesenchymal Stem Cells." She has served on more than 75 National Institutes of Health grant review panels and has been editor and editorial board member on six scientific journals.
Nolta also serves as the scientific director of the UC Davis GMP facility, which is located within the institute building in Sacramento. The custom-built cleanroom facility is one of the largest academic GMP laboratories in the nation and enables researchers to test and safely produce stem cell therapies for clinical trials. Her ultimate goal is to help teams develop more effective regenerative medicine therapies for patients who currently have few options.
Nolta had served as an associate editor at STEM CELLS since 2008. She begins her new editorial responsibilities as the journal celebrates its 30th anniversary.